CollPlant Biotechnologies (CLGN) is scheduled to report Q1 earnings on May 27, 2026. Analysts estimate EPS of $-0.24 and quarterly revenue of $1.45M.
In the most recent quarter (Q4), CollPlant Biotechnologies reported EPS of $-0.25, missing estimates of $-0.19 by 0.32%. Revenue came in at $60.00K, missing the estimate of $6.77M by 0.99%.
CollPlant Biotechnologies has missed EPS estimates in 5 consecutive quarters.
Over the last 4 quarters, CollPlant Biotechnologies has averaged an EPS surprise of 2.04% and a revenue surprise of 0.94%.
Analyze the earnings history of CollPlant Biotechnologies using advanced sorting and filters.
The chart below shows CollPlant Biotechnologies's reported EPS compared to analyst estimates over recent quarters.
The chart below shows CollPlant Biotechnologies's reported revenue compared to analyst estimates over recent quarters.
CollPlant Biotechnologies (CLGN) is scheduled to report earnings on May 27, 2026. The last reported earnings were for reported on March 26, 2026 for Q4.
The Actual EPS was $-0.25, which missed the estimate of $-0.19.
The Actual Revenue was $60.00K, which missed the estimate of $6.77M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-26 | $-0.25 | $-0.19 | -31.6 % |
| Q3 | 2025-11-26 | $-0.25 | $0.25 | -200.0 % |
| Q2 | 2025-08-20 | $-0.23 | $0.06 | -483.3 % |
| Q1 | 2025-05-28 | $-0.10 | $0 | -100.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-26 | $60.00K | $6.77M | -99.1 % |
| Q3 | 2025-11-26 | $77.00K | $13.73M | -99.4 % |
| Q2 | 2025-08-20 | $179.00K | $8.91M | -98.0 % |
| Q1 | 2025-05-28 | $2.06M | $9.76M | -78.9 % |